近日，邯郸市第一医院核医学科主任石俊岭带领团队成功开展我市首例Amyloid PET核医学影像技术，标志着我市在核医学诊断新技术领域取得重大突破 ...

Encouraging interim results have supported Roche’s decision to move trontinemab into a pivotal Phase III programme.

This finding suggests that a single positron emission tomography (PET) scan assessing amyloid beta protein levels in the brain could be sufficient to predict the rate of cognitive decline in ...

Levels of tau in the brain - measured either post-mortem or using PET imaging techniques - have ... Pharmacology "The long debate about tau vs beta-amyloid... will ultimately be resolved where ...

The discovery of biomarkers such as phospho-tau217 marked an important advancement in Alzheimer’s diagnosis. This particular ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced the launch of a new laboratory blood test designed to help ...

For decades, scientists have been testing a range of biologic medications that recognize and remove beta amyloid proteins ... they were able to remove more amyloid from the brain. But other biomarker ...

The technology – called Antibody Transport Vehicle (ATV): Amyloid beta – can be used to help amyloid-targeting drugs cross the blood brain barrier (BBB) more effectively, say the partners.

Quest Diagnostics introduces AD-Detect Abeta, a new laboratory blood test, to detect Alzheimer's disease without any PET ...